Results 21 to 30 of about 1,018,553 (196)

Liver graft rejection following immune checkpoint inhibitors treatment: a review

open access: yesMedical Oncology, 2019
Immune checkpoint inhibitors (ICIs) have demonstrated remarkable efficacy in a variety of solid tumors; nonetheless, they have not been well investigated and are still recognized as a relative contraindication for patients with a liver transplantation ...
Bo Hu, Xiaobo Yang, X. Sang
semanticscholar   +1 more source

Donor-Derived Cell-Free DNA to Diagnose Graft Rejection Post-Transplant: Past, Present and Future

open access: yesTransplantology, 2021
Donor-derived cell-free DNA (dd-cfDNA) is a non-invasive biomarker that is more sensitive and specific towards diagnosing any graft injury or rejection. Due to its applicability over all transplanted organs irrespective of age, sex, race, ethnicity, and ...
Naveen Kumar   +4 more
doaj   +1 more source

Innate allorecognition by monocytic cells and its role in graft rejection

open access: yesAmerican Journal of Transplantation, 2018
Innate recognition of microbial products and danger molecules by monocytes and macrophages has been well established; this is mediated primarily by pattern‐recognition receptors and is central to the activation of innate and adaptive immune cells ...
Fadi G Lakkis, X. Li
semanticscholar   +1 more source

Cellular rejection of pancreaticoduodenal graft

open access: yesВестник трансплантологии и искусственных органов, 2018
Aim. The evaluation of donor’s duodenum histological examination in diagnosis of pancreaticoduodenal graft rejection.Materials and methods. The 35-yo patient with terminal diabetic nephropathy undergone simultaneous retroperitoneal kidney and pancreas ...
A. V. Pinchuk   +6 more
doaj   +1 more source

An endothelial rejection line following Descemet stripping automated endothelial keratoplasty

open access: yesBMC Ophthalmology, 2020
Background The endothelial rejection line is rarely seen after Descemet stripping automated endothelial keratoplasties (DSAEKs). Here, we present a case of endothelial graft rejection with an endothelial rejection line occurring 1 year after the ...
Muhannad Alkhalifah   +3 more
doaj   +1 more source

Delayed allogeneic skin graft rejection in CD26-deficient mice

open access: yesCellular & Molecular Immunology, 2018
Organ transplantation is an effective therapeutic tool for treating many terminal diseases. However, one of the biggest challenges of transplantation is determining how to achieve the long-term survival of the allogeneic or xenogeneic transplant by, for ...
Xiangli Zhao   +5 more
semanticscholar   +1 more source

Approaches toward enhancing survival probability following deep anterior lamellar keratoplasty

open access: yesTherapeutic Advances in Ophthalmology, 2020
The greatest advantage of deep anterior lamellar keratoplasty over full-thickness corneal transplantation is the elimination of graft failure caused by endothelial rejection.
Sepehr Feizi, Amir A Azari
doaj   +1 more source

Prediction of Kidney Graft Rejection Using Artificial Neural Network

open access: yesHealthcare Informatics Research, 2017
Objectives Kidney transplantation is the best renal replacement therapy for patients with end-stage renal disease. Several studies have attempted to identify predisposing factors of graft rejection; however, the results have been inconsistent.
Leili Tapak   +3 more
semanticscholar   +1 more source

Impaired Function of Peripherally Induced Regulatory T Cells in Hosts at High Risk of Graft Rejection

open access: yesScientific Reports, 2016
Regulatory T cells (Tregs) are crucial for allograft survival. Tregs can be divided into thymus-derived natural Tregs (tTregs) and peripherally-derived induced Tregs (pTregs).
Takenori Inomata   +3 more
semanticscholar   +1 more source

HLA Antibody Incompatible Renal Transplantation: Long-term Outcomes Similar to Deceased Donor Transplantation

open access: yesTransplantation Direct, 2021
Background. HLA incompatible renal transplantation still remains one of best therapeutic options for a subgroup of patients who are highly sensitized and difficult to match but not much is known about its long-term graft and patient survival.
Nithya Krishnan, MD, FRCP   +14 more
doaj   +1 more source

Home - About - Disclaimer - Privacy